There’s No Need To Panic Or Freeze When It Comes To Thermo Fisher Scientific Inc. (NYSE: TMO)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

The company is listed on the NYSE and operates within the Diagnostics & Research industry segment. At the end of the last regular session, the stock closed at $552.23 and fluctuated between $553.92 as its day high and $534.24 as its day low. The current market capitalization of Thermo Fisher Scientific Inc. is $213.37B. A total of 2.08 million shares were traded on the day, compared to an average of 1.86M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, TMO has seen 3 BUY and 16 SELL insider trades, representing the acquisition of 21,600 and the disposition of 20,836 shares. Over the last 12 months, there were 44 BUYs and 176 SELLs from insiders. Insiders purchased 205,516 shares during that period but sold 208,516.

In the most recent transaction, CASPER MARC N sold 1,600 shares of TMO for 460.25 per share on Nov 07. After the transaction, the Chairman & CEO now owns 131,175 company shares. In a previous transaction on Nov 06, CASPER MARC N sold 10,000 shares at 454.41 per share. TMO shares that Chairman & CEO owns now total 131,175.

Among the insiders who sold shares, CASPER MARC N disposed of 10,000 shares on Nov 03 at a per-share price of $456.15. This resulted in the Chairman & CEO holding 131,175 shares of TMO after the transaction. In another insider transaction, CASPER MARC N sold 10,000 shares at $445.49 per share on Nov 02. Company shares held by the Chairman & CEO now total 131,175.


The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Thermo Fisher Scientific Inc. pays an annual dividend of $1.47, resulting in a dividend yield of 0.27%, and it has a price to earnings (P/E) ratio of 35.74. TMO’s most recent ex-dividend date was 12/14/2023 when it declared a $0.35 quarterly dividend that was paid in cash on 1/16/2024. Previously, the company paid the dividend on 10/13/2023 with an ex-dividend date of 9/14/2023. The TMO stock dividend was $0.35 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for TMO in the last 3 months, the mean price target is $589.59 with high estimates of $650.00 and low estimates of $520.00. In terms of 52-week highs and lows, TMO has a high of $597.54 and a low of $415.60.

As of this writing, TMO has an earnings estimate of $Thermo Fisher Scientific Inc per share for the current quarter. EPS was calculated based on a consensus of Altria Group, Inc. estimates, with a high estimate of $Toyota Motor Corporation per share and a lower estimate of $Direxion Daily 20-Yr Treasury B.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TMO’s latest balance sheet shows that the firm has $4.48B in Cash & Short Term Investments as of fiscal 2021. There were $34.87B in debt and $13.44B in liabilities at the time. Its Book Value Per Share was $117.32, while its Total Shareholder’s Equity was $40.98B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMO is Buy with a score of 4.39.

Most Popular

Related Posts